feed,title,long_url,short_url
Benzinga,Global Biological Therapies Outlook for Cancer 2021-2026: Monoclonal Antibodies Segment Expected to Grow to $124.1 billion in 2026 at a CAGR of 12.8% During 2021 to 2026,https://benzinga.com/pressreleases/21/10/g23219462/global-biological-therapies-outlook-for-cancer-2021-2026-monoclonal-antibodies-segment-expected-to,
